No Data
No Data
Cyron Biotech: Salen Biotech: 2024 Annual Results Express Announcement
Cyron Biotech: 2024 Annual Results Report Announcement
Siren Biotech (688163.SH) reported a net income of 45.3956 million yuan for the 2024 fiscal year, an increase of 17.08% year-on-year.
Sailun Biopharmaceuticals (688163.SH) released its performance forecast for the 2024 fiscal year, with total operating revenue for 2024...
Siren Biological (688163.SH): Appointed Liu Jinbao as the Chief Financial Officer.
Sailun Biotech (688163.SH) announced that the Board of Directors has recently received the resignation submitted by Chief Financial Officer Li Shaoyang...
Express News | Star market closing review: strong rise in the biopharmaceutical sector, active performance of robot concept stocks.
Express News | Star market closing review: individual stocks continue to shrink in volume, robot concept stocks weaken.